Fig. 3From: Prognostic significance of the CRAFITY score in hepatocellular carcinoma treated with immunotherapy: a systematic review and meta-analysisForest plot depicting improved progression-free survival outcomes among patients with low CRAFITY scores in the subgroup analysis according to BCLC stage. (A) The PFS outcomes of BCLC stage A/B/C/D patients. (B) The PFS outcomes of BCLC stage B/C/D patientsBack to article page